Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/1998
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998040375A3 COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
12/03/1998WO1998037873A3 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291674A1 5-ht1a and 5-ht1d.alpha. antagonists
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291254A1 1,6-naphthyridine anti-convulsants
12/03/1998CA2291251A1 Novel process
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881224A1 5-HT1A and 5-HT1D alpha antagonists
12/02/1998EP0881219A1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same
12/02/1998EP0881218A1 Preventives/remedies for complications of diabetes
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880501A1 Heterocyclic compounds useful as pharmaceutical agents
12/02/1998EP0592594B1 Colestipol hydrochloride high-content tablets
12/02/1998CN1200297A Phospholipid composite, prepn. method and application thereof
12/02/1998CN1200276A Medicine for lowering blood-sugar and nourishing the heart and method for preparing same
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843986 Tricyclic amide compounds
12/01/1998US5843976 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
12/01/1998US5843972 Heterocyclic β-adrenergic agonists
12/01/1998US5843965 Benzo B! thiophene compounds, intermediates, processes, compositions, and methods
12/01/1998US5843963 Benzothiophene compounds, intermediates, processes, compositions, and methods
12/01/1998US5843940 Benzothiophene compounds, compositions, and method
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843934 Uses of estrogen compounds for the treatment of disease
12/01/1998US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
12/01/1998US5843927 18,19-dinor-vitamin D compounds
12/01/1998US5843924 Intravenous alendronate formulations
12/01/1998US5843907 Pharmaceutical composition containing 2-O-α-d-glucopyranosyl-l-ascorbic acid
12/01/1998US5843906 Meta-substituted phenylene sulphonamide derivatives
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843890 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T
12/01/1998US5843886 Method of treating or preventing Type 1 diabetes by oral administration of insulin
12/01/1998US5843885 ICAM-1/LFA-1 short-chain peptides and method of using same
12/01/1998US5843476 Slimming composition for topical treatment, containing two types of liposomes, and use thereof
12/01/1998US5843430 Methods of treating disease using sertoli cells and allografts or xenografts
11/1998
11/30/1998CA2233554A1 Novel compounds
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052958A1 Human uncoupling protein 3
11/26/1998WO1998052947A1 Process for preparing 6-o-monoesters of castanospermine
11/26/1998WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052935A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998WO1998052602A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998DE19750422C1 Use of esters of phyto-sterols
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2289945A1 Human uncoupling protein 3
11/26/1998CA2288622A1 Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639)
11/25/1998EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998EP0879603A1 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof
11/25/1998EP0879286A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
11/25/1998EP0879279A1 Diabetes therapy
11/25/1998EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998EP0879223A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/25/1998EP0879058A1 Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments
11/25/1998EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998EP0810868A4 Use of piperine as a bioavailability enhancer
11/25/1998EP0759912B1 Di-oxadiazole derivatives as antihyperglycemic agents
11/25/1998EP0669835B1 Dietary hypocholesterolaemic compositions comprising soya proteins and sitosterols
11/25/1998EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998CN1200106A Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents
11/25/1998CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
11/25/1998CN1199731A Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
11/25/1998CN1040873C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, salts and composition and their application and producing process
11/24/1998US5840991 Antiatherosclerosis agents for lipid-lowering and antiperoxidative activity
11/24/1998US5840853 Parathyroid hormone receptor and DNA encoding same
11/24/1998US5840837 Coupling protected amino acids, optionally on a resin, deprotecting and purifying polypeptide product
11/24/1998US5840745 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
11/24/1998US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component
11/24/1998US5840705 α-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
11/24/1998US5840688 Having sequences corresponding to specific portions of apolipoprotein a-iv
11/24/1998US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs
11/24/1998US5840330 Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840294 Method for treating amyloidosis
11/23/1998CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/19/1998WO1998051686A1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists
11/19/1998WO1998051678A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
11/19/1998WO1998051668A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
11/19/1998WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998WO1998051408A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
11/19/1998WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998WO1998051348A2 Sustained-release delayed gels
1 ... 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 ... 1298